Identification of a novel, membrane-associated neuronal kinase, cyclin-dependent kinase 5/p35-regulated kinase

被引:0
|
作者
Kesavapany, S
Lau, KF
Ackerley, S
Banner, SJ
Shemilt, SJA
Cooper, JD
Leigh, PN
Shaw, CE
McLoughlin, DM
Miller, CCJ
机构
[1] Kings Coll London, Inst Psychiat, Dept Neurosci, London SE5 8AF, England
[2] Kings Coll London, Inst Psychiat, Dept Neurol, London SE5 8AF, England
来源
JOURNAL OF NEUROSCIENCE | 2003年 / 23卷 / 12期
基金
英国惠康基金; 英国医学研究理事会;
关键词
cdk5; p35; tau; neurofilament; Alzheimer's disease; amyotrophic lateral sclerosis;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Here we characterize a novel neuronal kinase, cyclin-dependent kinase 5 (cdk5)/p35-regulated kinase (cprk). Cprk is a member of a previously undescribed family of kinases that are predicted to contain two N-terminal membrane-spanning domains and a long C terminus, which harbors a dual-specificity serine/threonine/tyrosine kinase domain. Cprk was isolated in a yeast two-hybrid screen using the neuronal cdk5 activator p35 as "bait." Cprk interacts with p35 in the yeast-two hybrid system, binds to p35 in glutathione S-transferase fusion pull-down assays, and colocalizes with p35 in cultured neurons and transfected cells. In these cells, cprk is present with p35 in the Golgi apparatus. Cprk is expressed in a number of tissues but is enriched in brain and muscle and within the brain is found in a wide range of neuronal populations. Cprk displays catalytic activity in in vitro kinase assays and is itself phosphorylated by cdk5/p35. Cdk5/p35 inhibits cprk activity. Cdk5/p35 may therefore regulate cprk function in the brain.
引用
收藏
页码:4975 / 4983
页数:9
相关论文
共 50 条
  • [41] Cyclin-dependent kinase 6 is regulated by microRNA 124 in medulloblastoma
    Pierson, Jessica
    Fan, Rong
    Vibhakar, Rajeev
    NEURO-ONCOLOGY, 2008, 10 (03) : 377 - 377
  • [42] Cyclin-dependent kinase inhibitors: Cancer killers to neuronal guardians
    Monaco, EA
    Vallano, ML
    CURRENT MEDICINAL CHEMISTRY, 2003, 10 (05) : 367 - 379
  • [43] Neuronal morphogenesis is regulated by the interplay between cyclin-dependent kinase 5 and the ubiquitin ligase mind bomb 1
    Choe, Eun-Ah
    Liao, Lujian
    Zhou, Jian-Ying
    Cheng, Dongmei
    Duong, Duc M.
    Jin, Peng
    Tsai, Li-Huei
    Peng, Junmin
    JOURNAL OF NEUROSCIENCE, 2007, 27 (35): : 9503 - 9512
  • [44] Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
    Cui, Heying
    Loftus, Kyle M.
    Noell, Crystal R.
    Solmaz, Sozanne R.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2018, (135):
  • [45] Association of cyclin-dependent kinase 5 and its activator p35 with apoptotic cell death
    Ahuja, HS
    Zhu, Y
    Zakeri, Z
    DEVELOPMENTAL GENETICS, 1997, 21 (04): : 258 - 267
  • [46] p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment
    Ko, J
    Humbert, S
    Bronson, RT
    Takahashi, S
    Kulkarni, AB
    Li, E
    Tsai, LH
    JOURNAL OF NEUROSCIENCE, 2001, 21 (17): : 6758 - 6771
  • [47] Novel potent pharmacological cyclin-dependent kinase inhibitors
    Wesierska-Gadek, Jozefa
    Chamrad, Ivo
    Krystof, Vladimir
    FUTURE MEDICINAL CHEMISTRY, 2009, 1 (09) : 1561 - 1581
  • [48] A novel binding pocket of cyclin-dependent kinase 2
    Chen, Hao
    Van Duyne, Rachel
    Zhang, Naigong
    Kashanchi, Fatah
    Zeng, Chen
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2009, 74 (01) : 122 - 132
  • [49] P35 IS A NEURAL-SPECIFIC REGULATORY SUBUNIT OF CYCLIN-DEPENDENT KINASE-5
    TSAI, LH
    DELALLE, I
    CAVINESS, VS
    CHAE, T
    HARLOW, E
    NATURE, 1994, 371 (6496) : 419 - 423
  • [50] Cyclin-dependent kinase inhibitors: novel anticancer agents
    Mani, S
    Wang, CG
    Wu, KM
    Francis, R
    Pestell, R
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (08) : 1849 - 1870